Methods and compositions for treating biofilms
AssigneeUniversity Technologies International Inc.
InventorsDouglas Storey, Michael Parkins, Howard Ceri, James Davies, Merle Olson, Lyriam Marques
Life of this patent
Estimating the term…
Abstract
This disclosure relates to methods and compositions to regulate biofilm formation. In particular, the disclosure provides methods and compositions that relate to regulation of biofilm formation by modulating the GacA/GacS regulatory system as well as methods and compositions for inhibiting small colony variant formation and reversion of resistant bacteria to a wild-type phenotype.
Claims31
A method of preventing biofilm formation comprising inhibiting the gacA/gacS regulatory system of an organism.
A method of inhibiting the production of small colony variants (SCVs) comprising contacting a bacterial population with an antagonist of the gacA/gacS regulatory system of the bacteria.
A composition useful for preventing biofilm formation comprising an antagonist of a gacA/gacS regulatory system in a pharmaceutically acceptable form.
A method of treating an antimicrobial resistant biofilm, comprising:
- contacting a resistant bacteria in the biofilm comprising a mutation in gacS with a gacS agonist, wherein the gacS agonist generates a wild-type phenotype in the resistant bacteria.
A composition comprising a gacS agonist and a pharmaceutically acceptable carrier.
A method comprising inhibiting biofilm formation, comprising:
- contacting bacterial population with a gacS and/or gacA antagonist;
- monitoring the bacterial population for the formation of a small colony variant;
- contacting the small colony variant with a composition comprising gacS agonist.
Dependencies are inferred from the claim text.